Veeva Systems (VEEV) has risen sharply, recording gains of 1.33% in the past 4 weeks. However, the stock has corrected -0.86% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 1.87% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 0.86% and the 50-Day Moving Average is 4.72%.The 200 Day SMA reached 33.65%
Veeva Systems (NYSE:VEEV): The stock opened in the green at $41.69 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $41.774 and a low of $40.9 for the day. The stock did not find buyers even at the lows and closed at $41.28 recording a loss of -0.31%. 1,166,682 shares exchanged hands during the trading day. The stock had closed at $41.28 in the previous days trading.
Veeva Systems (VEEV) : The most positive equity analysts on Veeva Systems (VEEV) expects the shares to touch $48, whereas, the least positive believes that the stock will trade at $36 in the short term. The company is covered by 7 Wall Street Brokerage Firms. The average price target for shares are $42.71 with an expected fluctuation of $3.55 from the mean.
Veeva Systems Inc. (Veeva) is a provider of cloud-based software solutions for the global life sciences industry. The Companys industry cloud for life sciences consists of the solution sets: Veeva CRM, its core customer relationship management solution and related solutions; Veeva Vault, its regulated content management and collaboration solutions; Veeva Network, its customer master data management solution, and Veeva OpenKey, its data and related services offerings. It provides updates to its software solutions three times per year. Updates are included in its subscription and are not subject to an additional fee. Upgrades are implemented by Veeva in its cloud computing environment such that when a new update is put into production, the prior version is replaced. Veeva OpenKey customer data is available in Australia, China, France, Italy, the United Kingdom and the United States.